生物活性 | |||
---|---|---|---|
描述 | Nafamostat mesylate (FUT-175), a synthetic serine protease inhibitor, functions as an anticoagulant and exhibits both anticancer and antiviral effects. It is known to induce apoptosis by up-regulating the expression of tumor necrosis factor receptor-1 (TNFR1), and it is also used in studies related to the pathological thickening of arterial walls[1].[2]. |
临床研究 | |||||
---|---|---|---|---|---|
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01486485 | Acute Kidney Injury | Phase 3 | Unknown | August 2013 | Korea, Republic of ... 展开 >> National Health Insurance Corporation Ilsan Hospital Recruiting Koyang, Korea, Republic of Contact: Tae Ik Chang, MD 82-31-900-0246 tichang@hanmail.net Seoul National University Bundang Hospital Recruiting Seongnam, Korea, Republic of Contact: Sejoong Kim, MD, PhD 82-11-9196-5245 imsejoong@hanmail.net Seoul National University Boramae Medical Center Recruiting Seoul, Korea, Republic of Contact: Jung Pyo Lee, MD, PhD 82-2-870-2261 kjwa1@medimail.co.kr Seoul National University Hospital Recruiting Seoul, Korea, Republic of Contact: Su Mi Lee 82-2-2072-1705 promise131@hanmail.net 收起 << |
NCT01001403 | Liver Transplantation ... 展开 >> Postreperfusion Syndrome 收起 << | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 收起 << |
NCT01761994 | Acute Kidney Injury | Phase 4 | Completed | - | Korea, Republic of ... 展开 >> Severance Hospital Seoul, Korea, Republic of, 120-752 收起 << |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.85mL 0.37mL 0.19mL |
9.27mL 1.85mL 0.93mL |
18.53mL 3.71mL 1.85mL |
参考文献 |
---|